Please use this identifier to cite or link to this item: http://cmuir.cmu.ac.th/jspui/handle/6653943832/68526
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNapatra Tovanabutraen_US
dc.contributor.authorAimee S. Payneen_US
dc.date.accessioned2020-04-02T15:28:51Z-
dc.date.available2020-04-02T15:28:51Z-
dc.date.issued2020-01-01en_US
dc.identifier.issn10976787en_US
dc.identifier.issn01909622en_US
dc.identifier.other2-s2.0-85080075217en_US
dc.identifier.other10.1016/j.jaad.2019.11.023en_US
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85080075217&origin=inwarden_US
dc.identifier.urihttp://cmuir.cmu.ac.th/jspui/handle/6653943832/68526-
dc.subjectMedicineen_US
dc.titleClinical outcome and safety of rituximab therapy for pemphigoid diseasesen_US
dc.typeJournalen_US
article.title.sourcetitleJournal of the American Academy of Dermatologyen_US
article.stream.affiliationsUniversity of Pennsylvaniaen_US
article.stream.affiliationsChiang Mai Universityen_US
Appears in Collections:CMUL: Journal Articles

Files in This Item:
There are no files associated with this item.


Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.